GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock

Update Il y a 4 ans
Reference: NCT01315496

Woman and Man

Extract

This study is to determine whether the intravenous application of 'Ⅳ-Globulin S inj. (Human Immunoglobulin G)' can reduce mortality in patients with severe sepsis or septic shock.


Inclusion criteria

  • Severe sepsis ,Septic shock

Links